In vivo perturbations and single-cell RNA-seq reveal cell-type-specific STAT1-IFNg signaling in regulation of trained immunity in tissue-resident immune cells.

Extramedullary lesions in patients with chronic myeloid leukaemia (CML) suggest progression to the blast phase because such lesions generally consist of immature granulocytes. We here report a case of ...

Acute Myeloid Leukaemia (AML) with Retinoic acid receptor-gamma (RARG) fusions have similarities to Acute Promyelocytic Leukemia (APL) but are not responsive to standard APL treatments.

Researchers identify a pathogenic subset of CD8+ memory T-cells that promote airway tissue inflammation and recurrent ...

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today ...

TC BioPharm (NASDAQ: TCBP) , a clinical-stage biotech company, announced plans to initiate Proof of Concept preclinical studies for its lead therapy, ...

H5N1 is a viral infection often contracted by contact with sick birds, yet it can also be passed from person to person.

Hundreds of FDA-approved drugs tested directly on a patient’s tumor sample. Could this be a gamechanger for cancer management ...

TC BioPharm (NASDAQ: TCBP) , a clinical-stage biotechnology company advancing allogeneic gamma-delta T cell therapies for cancer and other diseases, ...

After hours: January 17 at 5:48:15 PM EST Loading Chart for MBRX ...

Stock analysts at Roth Capital issued their FY2029 earnings per share estimates for Moleculin Biotech in a research note issued on Thursday, January 9th. Roth Capital analyst J. Aschoff expects that ...